Fused pyrimidine derivatives and antiatherosclerotic methods of treatment with them
US4252807A · kind A · utility
3Cited by
8References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 8, 1978 |
| Grant date | Feb 24, 1981 |
| Priority date | — |
| Expiry date | Aug 8, 1998 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An optically active or racemic fused pyrimidine derivative of the formula I ##STR1## has pharmaceutical activity in decreasing serum lipids, cholesterol deposits and, in general, against atherosclerosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.